Interruption of pregnancy in rats by various fluoroandrostane derivatives.
D000019:Abortifacient Agents; D000028:Abortion, Induced; D000284:Administration, Oral; D000735:Androstenedione / Q000031:analogs & derivatives* / Q000494:pharmacology; D000736:Androstenes / Q000494:pharmacology*; D000818:Animals; D003270:Contraceptive Agents / Q000494:pharmacology; D003281:Contraceptives, Postcoital / Q000494:pharmacology; D005260:Female; D005474:Fluoxymesterone / Q000494:pharmacology; D006914:Hydroxysteroids / Q000494:pharmacology; D007279:Injections, Subcutaneous; D007664:Ketosteroids / Q000494:pharmacology; D008777:Methyltestosterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009929:Organ Size; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D051381:Rats; D013259:Steroids, Fluorinated / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects
D000019:Abortifacient Agents; D000736:Androstenes; D003270:Contraceptive Agents; D003281:Contraceptives, Postcoital; D006914:Hydroxysteroids; D007664:Ketosteroids; D013259:Steroids, Fluorinated; D000735:Androstenedione; D011374:Progesterone; D011388:Prolactin; D005474:Fluoxymesterone; D008777:Methyltestosterone